Nucleus Network
Nucleus Network
Saint Paul, Minnesota, United States5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel) | Healthy Participants | Recruiting | Phase 1 | 2026-09-03 | NCT07539090 | |
| Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Sexual Dysfunctions, Psychological, Urogenital Diseases, female reproductive system disorder, male reproductive system disorder, physiological sexual disorder, psychiatric disorder, psychologic dyspareunia | Recruiting | Phase 2 | 2026-05-22 | NCT06197568 | |
| A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 1 | 2026-05-12 | NCT07315360 | |
| Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperoxaluria, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, kidney disorder, metabolic disease, primary hyperoxaluria, primary hyperoxaluria type 1, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2026-02-12 | NCT06839235 | |
| A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD | Chronic Disease, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, asthma, bronchial disorder, chronic obstructive pulmonary disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Phase 1 | 2025-11-05 | NCT07116889 |